{"transactions":[{"id":739806,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-06-13T00:04:44.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":3355,"price":10,"value":33550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,907 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan (the \"ESPP\") on June 30, 2025 and 1,745 shares acquired under the ESPP on December 31, 2025."}],"balance_after":90910,"source":{"system":"sec-edgar","filing":"0001398595-26-000004","document":"form4-06132026_120640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000139859526000004/form4-06132026_120640.xml","form_type":"4"}},{"id":951493,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-01-05T21:25:06.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2026."}],"balance_after":240000,"derivative":{"exercise_price":11.49,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001398595-26-000002","document":"form4-01052026_090101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000139859526000002/form4-01052026_090101.xml","form_type":"4"}},{"id":1137197,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-22T21:00:13.000Z","date":"2025-05-20","kind":"exercise","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vested on January 1, 2025, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":200000,"derivative":{"exercise_price":5.58,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-014186","document":"form4-05222025_050505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925014186/form4-05222025_050505.xml","form_type":"4"}},{"id":1137196,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-05-22T21:00:13.000Z","date":"2025-05-20","kind":"sale","planned":false,"acquired":false,"shares":102969,"price":14.0966,"value":1451512.8054,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $14.0966 and the range of prices were between $14.02 and $14.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":89613,"source":{"system":"sec-edgar","filing":"0001415889-25-014186","document":"form4-05222025_050505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925014186/form4-05222025_050505.xml","form_type":"4"}},{"id":1137195,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-05-22T21:00:13.000Z","date":"2025-05-20","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":5.58,"value":558000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,355 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on December 31, 2024."}],"balance_after":192582,"source":{"system":"sec-edgar","filing":"0001415889-25-014186","document":"form4-05222025_050505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925014186/form4-05222025_050505.xml","form_type":"4"}},{"id":1314780,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-01-03T21:30:47.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":152300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025."}],"balance_after":152300,"derivative":{"exercise_price":10.71,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":152300},"source":{"system":"sec-edgar","filing":"0001415889-25-000463","document":"form4-01032025_040130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925000463/form4-01032025_040130.xml","form_type":"4"}},{"id":1687836,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-01-04T21:38:57.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":300000,"derivative":{"exercise_price":5.58,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-24-000804","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919124000804/doc4.xml","form_type":"4"}},{"id":1770478,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-10-02T20:23:09.000Z","date":"2023-09-29","kind":"purchase","planned":false,"acquired":true,"shares":46258,"price":3.783,"value":174994.014,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.70 to $3.85, inclusive. Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":89227,"source":{"system":"sec-edgar","filing":"0001209191-23-051073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123051073/doc4.xml","form_type":"4"}},{"id":1770477,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-10-02T20:23:09.000Z","date":"2023-09-28","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":3.624,"value":144960.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is the weighted average price.  The shares were purchased in multiple transactions at prices ranging from $3.60 to $3.64, inclusive.  Upon request by the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,969 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on June 30, 2023."}],"balance_after":42969,"source":{"system":"sec-edgar","filing":"0001209191-23-051073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123051073/doc4.xml","form_type":"4"}},{"id":2062720,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-01-05T22:00:51.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on December 1, 2023, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":700000,"derivative":{"exercise_price":8.42,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001209191-23-001931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123001931/doc4.xml","form_type":"4"}},{"id":2377635,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock option (right to buy)","published_at":"2022-02-23T16:08:06.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 18, 2022."}],"balance_after":300000,"derivative":{"exercise_price":0.49,"expiration_date":"2032-02-18","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001618835-22-000031","document":"wf-form4_164565046081887.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883522000031/wf-form4_164565046081887.xml","form_type":"4"}},{"id":2377634,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-02-23T16:08:06.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2022."}],"balance_after":516422,"source":{"system":"sec-edgar","filing":"0001618835-22-000031","document":"wf-form4_164565046081887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883522000031/wf-form4_164565046081887.xml","form_type":"4"}},{"id":2447760,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-01-04T16:06:28.000Z","date":"2021-12-31","kind":"disposition_to_issuer","acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The disposition is due to forfeiture under the vesting provisions of restricted stock awards granted on 2/3/2021."}],"balance_after":216422,"source":{"system":"sec-edgar","filing":"0001618835-22-000006","document":"wf-form4_164133035440575.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883522000006/wf-form4_164133035440575.xml","form_type":"4"}},{"id":2463579,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-12-20T16:20:47.000Z","date":"2021-12-20","kind":"purchase","acquired":true,"shares":25000,"price":0.389,"value":9725.0,"ownership":{"direct":true},"balance_after":336422,"source":{"system":"sec-edgar","filing":"0001618835-21-000273","document":"wf-form4_164003523317319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883521000273/wf-form4_164003523317319.xml","form_type":"4"}},{"id":2673480,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-06-10T19:29:40.000Z","date":"2021-06-10","kind":"purchase","acquired":true,"shares":10000,"price":1.025,"value":10250.0,"ownership":{"direct":true},"balance_after":311422,"source":{"system":"sec-edgar","filing":"0001618835-21-000146","document":"wf-form4_162336776279756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883521000146/wf-form4_162336776279756.xml","form_type":"4"}},{"id":2700433,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-05-21T16:26:55.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":42120,"price":0.86,"value":36223.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 20, 2021. No shares were sold in connection with this transaction."}],"balance_after":301422,"source":{"system":"sec-edgar","filing":"0001618835-21-000137","document":"wf-form4_162162880189777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883521000137/wf-form4_162162880189777.xml","form_type":"4"}},{"id":2880943,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock option (right to buy)","published_at":"2021-02-03T19:57:29.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 3, 2021."}],"balance_after":150000,"derivative":{"exercise_price":3.25,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001618835-21-000009","document":"wf-form4_161240022820711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883521000009/wf-form4_161240022820711.xml","form_type":"4"}},{"id":2880942,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-02-03T19:57:29.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2021."}],"balance_after":343542,"source":{"system":"sec-edgar","filing":"0001618835-21-000009","document":"wf-form4_161240022820711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883521000009/wf-form4_161240022820711.xml","form_type":"4"}},{"id":2974550,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2020-11-18T17:14:50.000Z","date":"2020-11-17","kind":"purchase","acquired":true,"shares":9090,"price":2.2,"value":19998.0,"ownership":{"direct":true},"balance_after":143542,"source":{"system":"sec-edgar","filing":"0001618835-20-000246","document":"wf-form4_160573767675790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883520000246/wf-form4_160573767675790.xml","form_type":"4"}},{"id":3118200,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2020-06-08T17:41:53.000Z","date":"2020-06-05","kind":"tax_withholding","acquired":false,"shares":31590,"price":3.31,"value":104562.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on June 5, 2020. No shares were sold in connection with this transaction."}],"balance_after":134452,"source":{"system":"sec-edgar","filing":"0001618835-20-000185","document":"wf-form4_159165249625617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883520000185/wf-form4_159165249625617.xml","form_type":"4"}},{"id":3134764,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2020-05-26T17:16:54.000Z","date":"2020-05-22","kind":"tax_withholding","acquired":false,"shares":39487,"price":4.99,"value":197040.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 22, 2020. No shares were sold in connection with this transaction."}],"balance_after":166042,"source":{"system":"sec-edgar","filing":"0001618835-20-000158","document":"wf-form4_159052779414010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883520000158/wf-form4_159052779414010.xml","form_type":"4"}},{"id":3156047,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2020-05-08T12:30:50.000Z","date":"2020-05-06","kind":"tax_withholding","acquired":false,"shares":7802,"price":5.24,"value":40882.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on May 6, 2020. No shares were sold in connection with this transaction."}],"balance_after":205529,"source":{"system":"sec-edgar","filing":"0001618835-20-000111","document":"wf-form4_158895543229158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883520000111/wf-form4_158895543229158.xml","form_type":"4"}},{"id":3284100,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock option (right to buy)","published_at":"2020-02-07T16:33:08.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 5, 2020."}],"balance_after":100000,"derivative":{"exercise_price":4.87,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001618835-20-000021","document":"wf-form4_158111117130256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883520000021/wf-form4_158111117130256.xml","form_type":"4"}},{"id":3284099,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2020-02-07T16:33:08.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2020."}],"balance_after":213331,"source":{"system":"sec-edgar","filing":"0001618835-20-000021","document":"wf-form4_158111117130256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883520000021/wf-form4_158111117130256.xml","form_type":"4"}},{"id":3358586,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2019-11-26T17:15:05.000Z","date":"2019-11-25","kind":"tax_withholding","acquired":false,"shares":7747,"price":6.22,"value":48186.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on November 25, 2019. No shares were sold in connection with this transaction."}],"balance_after":63331,"source":{"system":"sec-edgar","filing":"0001618835-19-000203","document":"wf-form4_157480648797283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883519000203/wf-form4_157480648797283.xml","form_type":"4"}},{"id":3362728,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2019-11-21T20:17:48.000Z","date":"2019-11-20","kind":"tax_withholding","acquired":false,"shares":7747,"price":5.74,"value":44467.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on November 20, 2019. No shares were sold in connection with this transaction."}],"balance_after":71078,"source":{"system":"sec-edgar","filing":"0001618835-19-000182","document":"wf-form4_157438545260854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883519000182/wf-form4_157438545260854.xml","form_type":"4"}},{"id":3391592,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2019-10-17T14:15:37.000Z","date":"2019-10-16","kind":"tax_withholding","acquired":false,"shares":18427,"price":5.01,"value":92319.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on October 16, 2019. No shares were sold in connection with this transaction."}],"balance_after":78825,"source":{"system":"sec-edgar","filing":"0001628280-19-012348","document":"wf-form4_157133610914438.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000162828019012348/wf-form4_157133610914438.xml","form_type":"4"}},{"id":3429126,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2019-08-26T18:36:26.000Z","date":"2019-08-22","kind":"tax_withholding","acquired":false,"shares":1296,"price":5.13,"value":6648.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on August 22, 2019. No shares were sold in connection with this transaction."}],"balance_after":97252,"source":{"system":"sec-edgar","filing":"0001618835-19-000154","document":"wf-form4_156685897030733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883519000154/wf-form4_156685897030733.xml","form_type":"4"}},{"id":3492368,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2019-06-12T16:38:33.000Z","date":"2019-06-10","kind":"tax_withholding","acquired":false,"shares":7777,"price":6.36,"value":49461.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on June 10, 2019. No shares were sold in connection with this transaction."}],"balance_after":98548,"source":{"system":"sec-edgar","filing":"0001618835-19-000123","document":"wf-form4_156037189920094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883519000123/wf-form4_156037189920094.xml","form_type":"4"}},{"id":3563895,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2019-04-03T18:42:20.000Z","date":"2019-04-01","kind":"tax_withholding","acquired":false,"shares":1298,"price":3.55,"value":4607.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on April 1, 2019. No shares were sold in connection with this transaction."}],"balance_after":106325,"source":{"system":"sec-edgar","filing":"0001618835-19-000049","document":"wf-form4_155433132454011.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883519000049/wf-form4_155433132454011.xml","form_type":"4"}},{"id":3628714,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2019-02-27T16:10:43.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2019."}],"balance_after":107623,"source":{"system":"sec-edgar","filing":"0001618835-19-000019","document":"wf-form4_155130182924120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883519000019/wf-form4_155130182924120.xml","form_type":"4"}},{"id":3745581,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock option (right to buy)","published_at":"2018-12-03T12:51:16.000Z","date":"2018-11-28","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4, filed on November 29, 2018, is being amended to update the number of shares reported in Column 5(A) and Column 7 of Table II."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from November 28, 2018."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The original Form 4, filed on November 29, 2018, is being amended to update the number of shares reported in Column 5(A) and Column 7 of Table II."}],"balance_after":100000,"derivative":{"exercise_price":3.45,"expiration_date":"2028-11-28","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001618835-18-000129","document":"wf-form4a_154385946011509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883518000129/wf-form4a_154385946011509.xml","form_type":"4/A","original_submission_date":"2018-11-29"}},{"id":3748631,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock option (right to buy)","published_at":"2018-11-29T18:10:38.000Z","date":"2018-11-28","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from November 28, 2018."}],"balance_after":100000,"derivative":{"exercise_price":3.45,"expiration_date":"2028-11-28","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001618835-18-000117","document":"wf-form4_154353301888940.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883518000117/wf-form4_154353301888940.xml","form_type":"4"}},{"id":3787947,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2018-10-17T12:43:37.000Z","date":"2018-10-16","kind":"tax_withholding","acquired":false,"shares":17377,"price":3.78,"value":65685.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on October 16, 2018. No shares were sold in connection with this transaction."}],"balance_after":57623,"source":{"system":"sec-edgar","filing":"0001618835-18-000092","document":"wf-form4_153979460163169.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883518000092/wf-form4_153979460163169.xml","form_type":"4"}},{"id":3836962,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2018-08-21T16:06:11.000Z","date":"2018-08-21","kind":"purchase","acquired":true,"shares":500,"price":2.27,"value":1135.0,"ownership":{"direct":true},"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001618835-18-000090","document":"wf-form4_153488195492075.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883518000090/wf-form4_153488195492075.xml","form_type":"4"}},{"id":3836961,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2018-08-21T16:06:11.000Z","date":"2018-08-20","kind":"purchase","acquired":true,"shares":4500,"price":2.2,"value":9900.0,"ownership":{"direct":true},"balance_after":74500,"source":{"system":"sec-edgar","filing":"0001618835-18-000090","document":"wf-form4_153488195492075.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883518000090/wf-form4_153488195492075.xml","form_type":"4"}},{"id":3854734,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock option (right to buy)","published_at":"2018-08-02T16:23:08.000Z","date":"2018-07-31","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from July 31, 2018."}],"balance_after":104500,"derivative":{"exercise_price":2.1,"expiration_date":"2028-07-31","underlying":"Common Stock","underlying_shares":104500},"source":{"system":"sec-edgar","filing":"0001618835-18-000077","document":"wf-form4_153324137208204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883518000077/wf-form4_153324137208204.xml","form_type":"4"}},{"id":3874123,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2018-07-03T16:57:08.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock awards vest in two equal installments on each of October 16, 2018 and 2019 subject to Mr. Fitzpatrick's continued employment."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001618835-18-000047","document":"wf-form4_153065141230310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000161883518000047/wf-form4_153065141230310.xml","form_type":"4"}},{"id":3995986,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":38730,"kind":"person","name":"Fitzpatrick Alexander A","position":1,"cik":"0001398595","reported_name":"Fitzpatrick Alexander A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock option (right to buy)","published_at":"2018-03-14T17:19:37.000Z","date":"2018-03-12","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Fitzpatrick acquired a vested interest in 25% of the shares of common stock exercisable pursuant to the option effective as of March 12, 2018 (the \"Vesting Start Date\"). The remaining shares shall vest in a series of twenty-four (24) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from the Vesting Start Date. The option was awarded in connection with Mr. Fitzpatrick's service as Secretary and General Counsel."}],"balance_after":275000,"derivative":{"exercise_price":7.29,"expiration_date":"2028-03-12","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001209191-18-019640","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398595/000120919118019640/doc4.xml","form_type":"4"}}]}